<sup>131</sup>I治疗Graves病规范化建设体会

¹³¹I治疗Graves病规范化建设体会

摘要:
目的建立¹³¹I治疗Graves病规范化措施，保障医疗安全和医疗质量。
方法制定¹³¹I治疗Graves病的组织措施和技术措施，对Graves病患者进行¹³¹I规范化治疗并定期随访。
结果接受¹³¹I治疗的104例患者，随访6~36月，均无不良反应发生，一次治愈率为59.6%，有效率为99.9%，疗效满意。
结论 ¹³¹I治疗Graves病规范化建设是医疗质量和医疗安全的重要保证。

Abstract:
Objective To establish the normative and standard measures, to ensure medical safety and quality of care of the patients with Graves disease treated by ¹³¹I therapy.
Methods Formulating and strictly implementing the medical organizational and technical measures of ¹³¹I therapy for Graves disease and regular follow-up.
Results Receiving ¹³¹I treatment of 104 patients, follow-up 6－36 months, no adverse events, the cure rate of 59.6%, the efficient rate is 99.9%.
Conclusion It is important guarantee for the medical quality and safety to standardize the ¹³¹I therapy of Graves disease.